Is Risperidone an SSRI? The Answer and Key Differences

Risperidone is not an SSRI. It belongs to an entirely different class of psychiatric medication called atypical antipsychotics, and the two drug types work through distinct mechanisms in the brain. The confusion is understandable, though, because both risperidone and SSRIs involve serotonin, both are prescribed for overlapping conditions, and they are sometimes used together. But the way each drug interacts with serotonin, the receptors it targets, and the conditions it treats differ in ways that matter for anyone taking either medication or trying to understand a prescription.

How SSRIs Work

SSRIs, or selective serotonin reuptake inhibitors, are a class of antidepressant. Common examples include fluoxetine (Prozac), sertraline (Zoloft), escitalopram (Lexapro), and paroxetine (Paxil). They work by blocking the serotonin transporter, a protein that normally pulls serotonin back into the nerve cell after it has been released. By blocking that transporter, SSRIs increase the amount of serotonin lingering in the gap between nerve cells, which over time helps regulate mood.¹ At the doses typically prescribed, SSRIs occupy roughly 70 to 80 percent of serotonin transporters, and pushing occupancy higher doesn’t tend to improve effectiveness but does increase the chance of side effects.²

SSRIs are primarily prescribed for depression and anxiety disorders. They are also used for obsessive-compulsive disorder (OCD), panic disorder, post-traumatic stress disorder, and certain other conditions. As a class, SSRIs account for close to half of all antidepressant prescriptions in the United States.¹ Their side-effect profile is generally considered milder than older antidepressants, though they can still cause sexual dysfunction, weight changes, and gastrointestinal upset.

How Risperidone Works

Risperidone (brand name Risperdal) is an atypical, or second-generation, antipsychotic. Rather than boosting serotonin levels the way an SSRI does, risperidone blocks specific receptors that serotonin and dopamine bind to. Its two primary targets are the dopamine D2 receptor and the serotonin 5-HT2A receptor.³ It has an extremely strong affinity for the 5-HT2A receptor, a strong affinity for D2, and also binds to alpha-1 and alpha-2 adrenergic receptors and histamine H1 receptors.⁴ That multi-receptor profile is what makes it “atypical” compared to older antipsychotics, which mostly just blocked dopamine.

The distinction matters. An SSRI keeps more serotonin floating around in synapses by blocking its cleanup. Risperidone sits on specific serotonin and dopamine receptors and prevents those receptors from being activated. One is like leaving water in a bathtub by plugging the drain. The other is like capping the faucet’s spout so water can’t flow out even if it’s there. Both involve serotonin, but the mechanisms are fundamentally different.

The development of risperidone followed from research showing that incorporating serotonin antagonism alongside dopamine blockade could improve the treatment of schizophrenia, particularly the so-called negative symptoms like social withdrawal and flat affect that older antipsychotics handled poorly.⁵ Its FDA-approved uses include schizophrenia, bipolar mania, and irritability associated with autism in children and adolescents.

Why the Confusion Happens

Several things feed the misunderstanding. Both drugs involve serotonin. Both are prescribed in psychiatric settings. And risperidone is sometimes prescribed alongside SSRIs or even added to treat depression that hasn’t responded to antidepressants alone. To a patient Googling their new prescription, the serotonin connection can make these drugs look like variations of the same thing.

There’s also a naming problem that the psychiatric field itself has acknowledged. The traditional label “antipsychotic” implies the drug is only for psychosis, which discourages patients who are prescribed risperidone for non-psychotic conditions like irritability or treatment-resistant depression. A patient receiving an “antipsychotic” for depression might reasonably think the prescription is wrong and go looking for what the drug “really” is, landing on the serotonin connection and assuming it must be some kind of SSRI.⁶ Leading psychopharmacology organizations have proposed a neuroscience-based naming system that would classify drugs by their actual brain targets and mechanisms rather than by the condition they were originally marketed for, partly to reduce this kind of confusion.⁷

Different Side-Effect Profiles

Because risperidone and SSRIs act on different targets, their side effects overlap only partially and differ in important ways.

Risperidone is one of the antipsychotics most likely to raise prolactin, a hormone that can cause breast tenderness, menstrual irregularities, and sexual dysfunction. Typical (older) antipsychotics and risperidone are the most significant offenders in this category.⁸ SSRIs can also cause sexual dysfunction, but through a different route: their serotonergic activity tends to delay orgasm and reduce libido rather than working through prolactin.⁹ In a systematic review of male sexual function, risperidone showed higher odds of erectile and ejaculatory dysfunction compared to some other atypical antipsychotics.¹⁰

Weight gain is another area where the two classes diverge. Among atypical antipsychotics, risperidone carries a medium risk for weight gain and blood sugar problems. It’s less problematic than clozapine or olanzapine but more so than aripiprazole or ziprasidone.¹¹ Overall, metabolic risk tends to be lower with antidepressants than with antipsychotics, though some SSRIs like paroxetine can cause weight gain of their own.¹²

Risperidone can also cause movement-related side effects, sometimes called extrapyramidal symptoms: stiffness, tremor, restlessness, or involuntary movements. These tend to be dose-dependent and are more common at higher doses.⁸ SSRIs essentially don’t carry this risk. On the flip side, SSRIs are more commonly associated with gastrointestinal symptoms like nausea and diarrhea, especially when starting treatment, which aren’t typical complaints with risperidone.

When Risperidone and SSRIs Are Prescribed Together

One of the reasons people wonder whether risperidone is an SSRI is that the two are sometimes prescribed in combination. This typically happens in two clinical situations: augmenting antidepressants for treatment-resistant depression, and boosting SSRI treatment for OCD that hasn’t responded adequately.

For depression, a randomized controlled trial found that adding risperidone to an ongoing antidepressant led to remission in about half of patients with difficult-to-treat depression after four weeks, compared to about a quarter on placebo. Quality of life also improved more in the risperidone group.¹³ Risperidone has also been described as an effective augmenting agent for treatment-resistant depression and obsessive-compulsive disorders more broadly.¹⁴

For OCD specifically, a double-blind trial found that half of patients whose OCD hadn’t responded to an SSRI alone improved when risperidone was added, versus none in the placebo group.¹⁵ Even very low doses of risperidone, as low as 0.5 mg, showed benefit in OCD patients who hadn’t responded to fluvoxamine (an SSRI).¹⁶

The fact that risperidone can enhance what an SSRI does might seem to suggest the two drugs are related. In practice, it’s the opposite: the combination works precisely because they act on different parts of the serotonin and dopamine systems. Adding a second SSRI to the first wouldn’t accomplish the same thing, because it would just be doing more of what the first drug already does.

A Drug Interaction Worth Knowing About

If you take risperidone alongside certain SSRIs, there’s a pharmacokinetic interaction that can change how much risperidone your body is exposed to. Fluoxetine (Prozac) is a potent inhibitor of the liver enzyme CYP2D6, which is one of the main enzymes responsible for breaking down risperidone. In patients taking both drugs, risperidone blood levels rose substantially. One study found that after four weeks of combined treatment, the active drug levels (risperidone plus its active metabolite) increased by an average of 75 percent, with individual increases ranging from 9 to over 200 percent.¹⁷

This isn’t just a laboratory finding. A large nationwide study found that patients prescribed risperidone along with strong CYP2D6-inhibiting SSRIs (like fluoxetine and paroxetine) ended up needing significantly more anticholinergic medications to manage movement side effects, compared to patients who took risperidone with escitalopram, an SSRI that doesn’t inhibit CYP2D6. The implication is clear: the SSRI was effectively raising risperidone levels enough to push more patients into movement-related side effects.¹⁸ If your doctor prescribes both drugs together, the choice of which SSRI matters. Escitalopram and sertraline are weaker CYP2D6 inhibitors than fluoxetine or paroxetine, and pairing them with risperidone tends to be less likely to cause this kind of interaction.

Risperidone in Children and Adolescents

One population where risperidone is commonly encountered, and where the SSRI question sometimes comes up, is children with autism spectrum disorder. Risperidone is one of only a handful of medications FDA-approved for managing irritability in children and adolescents with autism. In a follow-up study tracking children for 21 months after an initial trial, about two-thirds continued taking risperidone, and the drug was associated with meaningful improvement in disruptive behavior. However, increased appetite and weight gain were notable concerns.¹⁹

Many of these children are also taking other medications. In one study of children and adolescents on long-term risperidone, about half were simultaneously taking an SSRI, and about 70 percent were taking a stimulant. Interestingly, concurrent SSRI use was actually associated with less weight gain during risperidone treatment, not more, which surprised the researchers and is the opposite of what some clinicians might expect.²⁰ The reasons for this aren’t fully understood, but certain SSRIs have mild appetite-suppressing properties that may partially offset risperidone’s tendency to increase hunger.

What Happens When You Stop Each Drug

Discontinuation is another area where the two classes behave differently. Stopping an SSRI abruptly can produce a well-known withdrawal syndrome: dizziness, nausea, irritability, “brain zaps” (a buzzing or electric-shock sensation), and flu-like symptoms. This is common enough that most prescribing guidelines recommend tapering SSRIs gradually rather than stopping cold.

Stopping risperidone also comes with risks, but they look different. A synthesis of discontinuation evidence found that abrupt antipsychotic withdrawal resulted in discontinuation symptoms in roughly 37 to 70 percent of patients. Those symptoms can be physical (nausea, sweating), motor (restlessness, involuntary movements), and psychological (irritability, insomnia). Involuntary movements that emerge after stopping can sometimes persist for months.²¹ With risperidone specifically, there’s also a risk of psychotic relapse in patients who were taking it for schizophrenia or bipolar disorder, which isn’t a concern with SSRIs because SSRIs aren’t used for those conditions.

Risperidone’s Broader Receptor Profile

Part of what makes risperidone distinct from an SSRI, or from any antidepressant, is the sheer breadth of receptors it interacts with. Beyond its primary D2 and 5-HT2A targets, risperidone has notably high binding affinity for alpha-1 adrenergic receptors, which helps explain why dizziness and low blood pressure upon standing are common early side effects. It also binds to histamine H1 receptors, which contributes to sedation and appetite increase, and to alpha-2 adrenergic receptors.²²

SSRIs, by contrast, are comparatively clean drugs pharmacologically. They bind primarily to the serotonin transporter and have relatively little direct activity at dopamine, histamine, or adrenergic receptors. That narrower profile is a double-edged sword: SSRIs produce fewer of the sedation and metabolic effects associated with risperidone, but they also can’t address the dopamine-related symptoms that risperidone targets. The two drugs are complementary in some respects, but interchangeable in none.

Pharmacokinetic-pharmacodynamic modeling in animal studies has shown that risperidone and its active metabolite paliperidone occupy D2 and 5-HT2A receptors in the brain in a time- and dose-dependent fashion, with the 5-HT2A receptor being occupied at lower drug concentrations than D2.²³ This means that at low doses, risperidone is functioning more as a serotonin receptor blocker, and at higher doses the dopamine blockade becomes more prominent. That dose-dependent shift in receptor balance helps explain why low-dose risperidone can be useful as an add-on for OCD or depression (where the serotonin effects matter most) while higher doses are needed for psychosis (where dopamine blockade is central).

Practical Questions for Patients

If you’ve been prescribed risperidone and you’re wondering whether it’s basically an SSRI or whether the pharmacy made an error, the answer is straightforward: they are different drugs for different purposes, and the prescription is almost certainly intentional. Your prescriber may be using risperidone for an FDA-approved indication like schizophrenia, bipolar mania, or autism-related irritability, or for an off-label use like augmenting an antidepressant. Either way, it isn’t functioning as an antidepressant on its own and wouldn’t be a replacement for an SSRI if you need one.

If you’re taking both an SSRI and risperidone, tell every prescriber and pharmacist about both medications. The drug interaction between certain SSRIs and risperidone is well-documented, and your doctor may need to adjust doses or choose an SSRI that doesn’t interfere with risperidone metabolism. Fluoxetine and paroxetine are the SSRIs most likely to raise risperidone levels through enzyme inhibition.¹⁷ Signs that risperidone levels may be climbing too high include increased drowsiness, stiffness, restlessness, or tremor. Report these to your doctor rather than adjusting doses yourself, because the interaction can vary dramatically between individuals depending on genetics and other medications.

Neither drug should be stopped abruptly. Both SSRIs and risperidone require gradual tapering under medical supervision to minimize withdrawal effects and, in risperidone’s case, the risk of symptom relapse. If the label “antipsychotic” on your risperidone prescription feels alarming or confusing given your diagnosis, that’s a reasonable thing to bring up with your prescriber. As the field itself has recognized, the naming conventions are a legacy of an earlier era of drug classification and don’t always match how these medications are actually used today.⁶